Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 4
2008 1
2009 2
2010 1
2012 2
2013 2
2014 4
2015 5
2016 6
2017 10
2018 11
2019 10
2020 11
2021 13
2022 8
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.
Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, Kim BJ, Min BH, Choi CI, Shin CM, Tae CH, Gong CS, Kim DJ, Cho AE, Gong EJ, Song GJ, Im HS, Ahn HS, Lim H, Kim HD, Kim JJ, Yu JI, Lee JW, Park JY, Kim JH, Song KD, Jung M, Jung MR, Son SY, Park SH, Kim SJ, Lee SH, Kim TY, Bae WK, Koom WS, Jee Y, Kim YM, Kwak Y, Park YS, Han HS, Nam SY, Kong SH; Development Working Groups for the Korean Practice Guidelines for Gastric Cancer 2022 Task Force Team. Kim TH, et al. Among authors: han hs. J Gastric Cancer. 2023 Jan;23(1):3-106. doi: 10.5230/jgc.2023.23.e11. J Gastric Cancer. 2023. PMID: 36750993 Free PMC article. Review.
Transcriptional regulators of hepatic gluconeogenesis.
Oh KJ, Han HS, Kim MJ, Koo SH. Oh KJ, et al. Among authors: han hs. Arch Pharm Res. 2013 Feb;36(2):189-200. doi: 10.1007/s12272-013-0018-5. Epub 2013 Jan 30. Arch Pharm Res. 2013. PMID: 23361586 Review.
A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS, Kim SG, Kim YS, Jang SH, Kwon Y, Choi D, Huh T, Moon E, Ahn E, Seong JK, Kweon HS, Hwang GS, Lee DH, Cho KW, Koo SH. Han HS, et al. Mol Metab. 2022 Jan;55:101402. doi: 10.1016/j.molmet.2021.101402. Epub 2021 Nov 24. Mol Metab. 2022. PMID: 34838715 Free PMC article.
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Yen I, Shanahan F, Lee J, Hong YS, Shin SJ, Moore AR, Sudhamsu J, Chang MT, Bae I, Dela Cruz D, Hunsaker T, Klijn C, Liau NPD, Lin E, Martin SE, Modrusan Z, Piskol R, Segal E, Venkatanarayan A, Ye X, Yin J, Zhang L, Kim JS, Lim HS, Kim KP, Kim YJ, Han HS, Lee SJ, Kim ST, Jung M, Hong YH, Noh YS, Choi M, Han O, Nowicka M, Srinivasan S, Yan Y, Kim TW, Malek S. Yen I, et al. Among authors: han hs. Nature. 2021 Jun;594(7863):418-423. doi: 10.1038/s41586-021-03515-1. Epub 2021 May 5. Nature. 2021. PMID: 33953400 Clinical Trial.
MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma.
Son SM, Yun J, Kim DW, Jung YS, Han SB, Lee YH, Han HS, Woo CG, Lee HC, Lee OJ. Son SM, et al. Among authors: han hs. BMC Cancer. 2023 Sep 8;23(1):843. doi: 10.1186/s12885-023-11352-w. BMC Cancer. 2023. PMID: 37684602 Free PMC article.
90 results